Zu diesem Instrument liegen derzeit keine aktuellen Daten vor.
Anlageziel
The investment objective of the Sub-Fund is to achieve long-term capital growth and to create a positive societal impact through investment in an actively managed portfolio of equity securities of companies engaged in the health care sector. The Sub-Fund will invest, under normal market conditions, primarily in Equity and Equity-Related Securities of companies engaged in the health care sector, which are listed or traded on a Recognised Exchange and which companies may be selected from the Index. The Sub-Fund will consist of health care companies, which are companies classified in the health care category as per the Global Industry Classification Standard (GICS®) and / or those companies that otherwise, in the opinion of the Investment Manager, promote the philosophy of healthy lives and well-being for all and are innovative and capable of sustainable business development (“Health Care Companies”).
Stammdaten
WKN | A2QLWG |
ISIN | IE00BMH6QG20 |
Fondsgesellschaft | Nomura Asset Management U.K |
Kategorie | Branchen: Gesundheitswesen |
Währung | EUR |
Mindestanlage | 5 000,00 |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager | Michael X Li, Henry He |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 103,21 |
Fonds Volumen | 4 261 937,68 |
Total Expense Ratio (TER) | 1,95 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | 0,00 % |
Ausgabeaufschlag | 5,00 % |
Basisdaten
Auflagedatum | 25.01.2021 |
Depotbank | Brown Brothers Harriman Trustee Services (Ireland) Limited |
Zahlstelle | Nomura Bank (Schweiz) AG |
Domizil | Ireland |
Geschäftsjahr | 31.12.2023 |
Performancedaten
Veränderung Vortag | -0,20 |